Yixing Wu

626 total citations
34 papers, 474 citations indexed

About

Yixing Wu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yixing Wu has authored 34 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Pulmonary and Respiratory Medicine and 6 papers in Cancer Research. Recurrent topics in Yixing Wu's work include Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), MicroRNA in disease regulation (3 papers) and Sexual function and dysfunction studies (2 papers). Yixing Wu is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (5 papers), MicroRNA in disease regulation (3 papers) and Sexual function and dysfunction studies (2 papers). Yixing Wu collaborates with scholars based in China, United States and France. Yixing Wu's co-authors include Lingeng Lu, Puchang Lie, Zhuo Xiao, Guodong Liu, Jing Huang, Lingwen Zeng, Zhiyuan Fang, Cheng Zhang, Yimin Liu and Guido Menato and has published in prestigious journals such as SHILAP Revista de lepidopterología, Chemical Communications and Free Radical Biology and Medicine.

In The Last Decade

Yixing Wu

29 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yixing Wu China 10 264 90 84 77 57 34 474
Haijun Liu China 10 346 1.3× 62 0.7× 51 0.6× 82 1.1× 52 0.9× 13 506
Safir Ullah Khan China 13 206 0.8× 63 0.7× 78 0.9× 20 0.3× 53 0.9× 42 441
Yujie Shen China 14 335 1.3× 65 0.7× 148 1.8× 30 0.4× 70 1.2× 50 630
Giovanny Rodriguez Blanco United Kingdom 15 303 1.1× 47 0.5× 77 0.9× 51 0.7× 37 0.6× 36 570
Ling Tang China 16 300 1.1× 70 0.8× 116 1.4× 18 0.2× 113 2.0× 61 761
Pengfei Yang China 14 172 0.7× 72 0.8× 86 1.0× 20 0.3× 97 1.7× 25 577
Yiming Liu China 12 121 0.5× 45 0.5× 27 0.3× 51 0.7× 75 1.3× 32 546
Mengyao Jin United States 11 261 1.0× 64 0.7× 61 0.7× 66 0.9× 220 3.9× 14 700
Xiangqin Zheng China 12 201 0.8× 75 0.8× 63 0.8× 15 0.2× 23 0.4× 45 449
Deborah A. Knight United States 14 315 1.2× 25 0.3× 159 1.9× 54 0.7× 57 1.0× 23 754

Countries citing papers authored by Yixing Wu

Since Specialization
Citations

This map shows the geographic impact of Yixing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yixing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yixing Wu more than expected).

Fields of papers citing papers by Yixing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yixing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yixing Wu. The network helps show where Yixing Wu may publish in the future.

Co-authorship network of co-authors of Yixing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yixing Wu. A scholar is included among the top collaborators of Yixing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yixing Wu. Yixing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Li, et al.. (2025). HIF-1α protects cigarette-induced airway epithelial cell apoptosis in COPD by activating REDD1. International Immunopharmacology. 161. 115062–115062. 2 indexed citations
2.
Zhang, Yan, et al.. (2025). Advancements in pharmacological interventions for atopic dermatitis current strategies and future directions. Inflammopharmacology. 33(3). 1221–1236.
3.
Wu, Yixing, et al.. (2025). Exploring the mechanism of α-Bisabolol in the treatment of psoriasis based on network pharmacology and experimental validation. European Journal of Pharmacology. 999. 177433–177433.
4.
Ye, Zhiming, Ping Ding, Yan Wang, et al.. (2024). Epithelial mitochondrial fission-mediated PANoptosis is crucial for ulcerative colitis and its inhibition by saquinavir through Drp1. Pharmacological Research. 210. 107538–107538. 12 indexed citations
5.
Ge, Qinggang, et al.. (2024). Extracorporeal Closed-Loop Respiratory Regulation for Patients With Respiratory Difficulty Using a Soft Bionic Robot. IEEE Transactions on Biomedical Engineering. 71(10). 2923–2935. 6 indexed citations
6.
Wang, Nan, Weifeng Hong, Yixing Wu, et al.. (2024). Next‐generation spatial transcriptomics: unleashing the power to gear up translational oncology. SHILAP Revista de lepidopterología. 5(10). e765–e765. 3 indexed citations
7.
8.
Wu, Yixing, et al.. (2024). Comparisons between In-Check DIAL® and PF810® in evaluation and training inspiratory capacity for using dry powder inhalers. BMC Pulmonary Medicine. 24(1). 380–380. 1 indexed citations
9.
Wu, Yixing, et al.. (2024). Deciphering the molecular regulatory of RAB32/GPRC5A axis in chronic obstructive pulmonary disease. Respiratory Research. 25(1). 116–116.
10.
Wu, Yixing, Weiping Hu, Yan Chen, et al.. (2023). The Clinical Impact of Metagenomic Next-Generation Sequencing (mNGS) Test in Hospitalized Patients with Suspected Sepsis: A Multicenter Prospective Study. Diagnostics. 13(2). 323–323. 14 indexed citations
11.
Wu, Yixing, et al.. (2023). DNA nanoparticles targeting FOXO4 selectively eliminate cigarette smoke-induced senescent lung fibroblasts. Nanoscale Advances. 5(21). 5965–5973. 4 indexed citations
12.
13.
Wu, Yixing, Hongmei Zeng, Qing Yu, et al.. (2021). A Circulating Exosome RNA Signature Is a Potential Diagnostic Marker for Pancreatic Cancer, a Systematic Study. Cancers. 13(11). 2565–2565. 13 indexed citations
14.
Liu, Lan, et al.. (2018). Plasma glucose to glycated hemoglobin ratio: Method of differentiating fulminant type 1 diabetes from diabetic ketoacidosis. Annales d Endocrinologie. 80(1). 16–20. 5 indexed citations
15.
Yang, Chuntao, Li Chen, Na Li, et al.. (2018). Hydrogen sulfide primes diabetic wound to close through inhibition of NETosis. Molecular and Cellular Endocrinology. 480. 74–82. 71 indexed citations
16.
Song, Kedong, Shixiao Li, Meiling Wu, et al.. (2014). In vitro culture and oxygen consumption of NSCs in size-controlled neurospheres of Ca-alginate/gelatin microbead. Materials Science and Engineering C. 40. 197–203. 15 indexed citations
17.
Lu, Lingeng, Yixing Wu, Lingjun Zuo, Xingguang Luο, & Peter J. Large. (2013). Intestinal microbiome and digoxin inactivation: meal plan for digoxin users?. World Journal of Microbiology and Biotechnology. 30(3). 791–799. 8 indexed citations
18.
Wu, Yixing, et al.. (2012). High lead exposure is associated with telomere length shortening in Chinese battery manufacturing plant workers. Occupational and Environmental Medicine. 69(8). 557–563. 60 indexed citations
19.
Fang, Zhiyuan, Jing Huang, Puchang Lie, et al.. (2010). Lateral flow nucleic acid biosensor for Cu2+ detection in aqueous solution with high sensitivity and selectivity. Chemical Communications. 46(47). 9043–9043. 101 indexed citations
20.
Lu, Lingeng, Dionyssios Katsaros, Biyun Qian, et al.. (2009). Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II. European Journal of Cancer. 45(12). 2212–2218. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haijun Liu Breakdown of academic impact, for papers by Safir Ullah Khan Breakdown of academic impact, for papers by Yujie Shen Breakdown of academic impact, for papers by Giovanny Rodriguez Blanco Breakdown of academic impact, for papers by Ling Tang Breakdown of academic impact, for papers by Pengfei Yang Breakdown of academic impact, for papers by Yiming Liu Breakdown of academic impact, for papers by Mengyao Jin Breakdown of academic impact, for papers by Xiangqin Zheng Breakdown of academic impact, for papers by Deborah A. Knight
Rankless by CCL
2026